These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27926996)

  • 1. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.
    Yi B; Sahn JJ; Ardestani PM; Evans AK; Scott LL; Chan JZ; Iyer S; Crisp A; Zuniga G; Pierce JT; Martin SF; Shamloo M
    J Neurochem; 2017 Feb; 140(4):561-575. PubMed ID: 27926996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ
    Maurice T; Volle JN; Strehaiano M; Crouzier L; Pereira C; Kaloyanov N; Virieux D; Pirat JL
    Pharmacol Res; 2019 Jun; 144():315-330. PubMed ID: 31048034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.
    Gabbita SP; Srivastava MK; Eslami P; Johnson MF; Kobritz NK; Tweedie D; Greig NH; Zemlan FP; Sharma SP; Harris-White ME
    J Neuroinflammation; 2012 May; 9():99. PubMed ID: 22632257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of σ
    Maurice T; Goguadze N
    Adv Exp Med Biol; 2017; 964():213-233. PubMed ID: 28315274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative.
    Villard V; Espallergues J; Keller E; Vamvakides A; Maurice T
    J Psychopharmacol; 2011 Aug; 25(8):1101-17. PubMed ID: 20829307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model.
    Lv C; Wang L; Liu X; Yan S; Yan SS; Wang Y; Zhang W
    Neuropharmacology; 2015 Feb; 89():175-84. PubMed ID: 25261783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.
    Sahn JJ; Hodges TR; Chan JZ; Martin SF
    ChemMedChem; 2016 Mar; 11(6):556-61. PubMed ID: 26915462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    Baazaoui N; Iqbal K
    J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.
    Vázquez-Rosa E; Watson MR; Sahn JJ; Hodges TR; Schroeder RE; Cintrón-Pérez CJ; Shin MK; Yin TC; Emery JL; Martin SF; Liebl DJ; Pieper AA
    ACS Chem Neurosci; 2019 Mar; 10(3):1595-1602. PubMed ID: 30421909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
    Nguyen L; Lucke-Wold BP; Mookerjee S; Kaushal N; Matsumoto RR
    Adv Exp Med Biol; 2017; 964():133-152. PubMed ID: 28315269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang HR; Peng JH; Cheng XB; Shi BZ; Zhang MY; Xu RX
    Neurochem Res; 2015 Aug; 40(8):1583-92. PubMed ID: 26068144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).
    Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Pérez B; Clos MV; Badia A
    Neurodegener Dis; 2013; 11(3):129-40. PubMed ID: 22626981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease-like impaired cognition in endothelial-specific megalin-null mice.
    Dietrich M; Antequera D; Pascual C; Castro N; Bolos M; Carro E
    J Alzheimers Dis; 2014; 39(4):711-7. PubMed ID: 24254699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.